Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biosortia Microbiomics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Biosortia Microbiomics

Biosortia Microbiomics

Seed

Biosortia, the drug discovery innovator, modernizes and enhances the approach to explore 99% untapped potential.

HQ
Dublin, OH, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Biosortia Microbiomics, founded with the mission to revolutionize drug discovery, focuses on unlocking the vast untapped potential of microbiomes. The company aims to modernize and improve traditional methodologies, accessing the 99% of microbiomes previously unexplored. Their core services include industrial-scale microbiome mining and small molecule amplification, targeting pharmaceutical and biotech markets to discover novel therapeutics.

Notable figures associated with Biosortia include key advisors and a leadership team with extensive industry experience. The company has achieved significant milestones in advancing drug discovery technologies and forming key industry partnerships. Biosortia's impact lies in its innovative approach to exploring microbiomes, potentially leading to groundbreaking treatments and contributing to the advancement of medical science.

Biosortia Microbiomics - Similar Companies

DeepBiome Therapeutics logo

DeepBiome Therapeutics

Petri Bio logo

Petri Bio

petribio.com

Biomiic logo

Biomiic

MarvelBiome logo

MarvelBiome

marvelbiome.com

BiomeSense logo

BiomeSense

biomesense.com

The BioCollective logo

The BioCollective

Biota Technology logo

Biota Technology

biota.com

Cryptyx Bioscience logo

Cryptyx Bioscience

Fortis Biosciences logo

Fortis Biosciences

PathDrugomics logo

PathDrugomics

Pluton Biosciences logo

Pluton Biosciences

plutonbio.com

Metagenomix logo

Metagenomix

Persephone Biosciences logo

Persephone Biosciences

Resilient Biotics logo

Resilient Biotics

Microbiome Therapeutics logo

Microbiome Therapeutics

Biosortia Microbiomics - Quick Facts

Who are Biosortia Microbiomics' competitors?

Companies similar to Biosortia Microbiomics include DeepBiome Therapeutics, Petri Bio, Biomiic and MarvelBiome.

When was Biosortia Microbiomics founded?

Biosortia Microbiomics was founded in 2012.

Where is Biosortia Microbiomics' headquarters located?

Biosortia Microbiomics' headquarters is located in Dublin, OH, US.

When was Biosortia Microbiomics' last funding round?

Biosortia Microbiomics' most recent funding round was for $3.5M (USD) in October 2017.

How much has Biosortia Microbiomics raised to-date?

As of Oct 1, 2017, Biosortia Microbiomics has raised a total of $22M (USD).

How many employees does Biosortia Microbiomics have?

Biosortia Microbiomics has 36 employees as of Feb 4, 2024.

Biosortia Microbiomics - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software